Video above: FDA votes to authorize more COVID-19 boosters, mix-and-matching doses in some casesA booster dose of the Pfizer/BioNTech coronavirus vaccine was found to have a high efficacy — 95.6% — ...
The Food and Drug Administration will no longer approve COVID-19 booster shots for healthy adults and children without new clinical trials proving they are safe and effective. Heart transplant ...
The FDA plans to limit COVID-19 vaccine booster recommendations to those over 65 or with underlying health conditions. FDA officials question the necessity of annual boosters for healthy individuals ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. We witnessed a preview of the new FDA approach when the agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results